Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disrupting cancer cells’ biocircuits with interactome-based drugs: is ‘clinical’ innovation realistic?

1 Aug 2012

Abstract excerpt

Despite expectations, abundant scientific and clinical evidence now reveals that current reductionist science and single pathway-based cancer-targeted drugs provide isolated clinical success. Overa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to PARP inhibition in cancer therapy
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22967071
DOI: 10.1586/epr.12.37

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disrupting cancer cells’ biocircuits with interactome-based drugs: is ‘clinical’ innovation realistic?PMID 22967071Read ↗

Biology-driven cancer drug development: back to the futureSemantic proximity Read ↗

Cancer Therapies: Cellular and Molecular MechanismsSemantic proximity Read ↗

Lesionalized therapy beyond personalized therapy in cancer management.Semantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

Cancer complexity slows quest for cureSemantic proximity Read ↗

Key pathways as therapeutic targets.Semantic proximity Read ↗

Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSemantic proximity Read ↗

Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.Semantic proximity Read ↗

Bringing science to cancer therapy.Semantic proximity Read ↗

The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell TechnologiesSemantic proximity Read ↗

Pharmacogenomics in Practice: Why Traditional Medicine Still LeadsSemantic proximity Read ↗

The Evolution of Oncology Companion Diagnostics from Signal Transduction to Immuno-OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.